mouse active pai 1 elisa kit (Innovative Research Inc)
Innovative Research Inc is a verified supplier 
Innovative Research Inc manufactures this product 
94
Structured Review
Innovative Research Inc
mouse active pai 1 elisa kit
Mouse Active Pai 1 Elisa Kit, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 94/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+active+pai+1+elisa+kit/Mouse+Active+PAI-1+ELISA+Kit%2CMouse+PAI-1+Activity+ELISA+Kit/pm41720714-164-6-12
Average 94 stars, based on 21 article reviews
Mouse Active Pai 1 Elisa Kit, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 94/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+active+pai+1+elisa+kit/Mouse+Active+PAI-1+ELISA+Kit%2CMouse+PAI-1+Activity+ELISA+Kit/pm41720714-164-6-12
Average 94 stars, based on 21 article reviews
mouse active pai 1 elisa kit - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Activity Assay:Article Title: Intravenous miR-30c therapy confers dual neurovascular protection and improves long-term recovery after ischemic stroke Article Snippet: .. PAI-1 activity was measured using a Article Title: Intravenous miR-30c therapy confers dual neurovascular protection and improves long-term recovery after ischemic stroke. Article Snippet: .. PAI-1 activity was measured using a Enzyme-linked Immunosorbent Assay:Article Title: Intravenous miR-30c therapy confers dual neurovascular protection and improves long-term recovery after ischemic stroke Article Snippet: .. PAI-1 activity was measured using a Article Title: Hypoxia-inducible factor-1α mediates TGF-β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Article Snippet: Ueno M, Maeno T, Nomura M, Aoyagi-Ikeda K, Matsui H, Hara K, Tanaka T, Iso T, Suga T, Kurabayashi M. Hypoxiainducible factor-1 mediates TGF-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis.. Am J Physiol Lung Cell Mol Physiol 300: L740 –L752, 2011.. First published January 14, 2011; doi:10.1152/ajplung.00146.2010.—Hypoxia-inducible factor-1 (HIF-1 ), a transcription factor that functions as a master regulator of oxygen homeostasis, has been implicated in fibrinogenesis. Article Title: Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts Article Snippet: The degrees of expression for E-cadherin, α-SMA, and vimentin were quantified by measuring fluorescence intensities of Alexa Fluor 488 or eFluor 615 per each field using software (BZ-analysis application, Keyence). .. PAI-1 levels in the supernatant of cell cultures or bronchoalveolar lavage fluid (BALF) were measured using human total, human active, or Article Title: Reversing PAI-1 deficiency in blood using mRNA lipid nanoparticles Article Snippet: .. The plasma PAI-1 concentration was analyzed with a mouse total PAI-1 ELISA kit (IMSPAI1KTT, Innovative Research, Novi, MI) and the active plasma PAI-1 concentration was analyzed with a Article Title: Intravenous miR-30c therapy confers dual neurovascular protection and improves long-term recovery after ischemic stroke. Article Snippet: .. PAI-1 activity was measured using a Concentration Assay:Article Title: Hypoxia-inducible factor-1α mediates TGF-β-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis. Article Snippet: Ueno M, Maeno T, Nomura M, Aoyagi-Ikeda K, Matsui H, Hara K, Tanaka T, Iso T, Suga T, Kurabayashi M. Hypoxiainducible factor-1 mediates TGF-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis.. Am J Physiol Lung Cell Mol Physiol 300: L740 –L752, 2011.. First published January 14, 2011; doi:10.1152/ajplung.00146.2010.—Hypoxia-inducible factor-1 (HIF-1 ), a transcription factor that functions as a master regulator of oxygen homeostasis, has been implicated in fibrinogenesis. Article Title: Reversing PAI-1 deficiency in blood using mRNA lipid nanoparticles Article Snippet: .. The plasma PAI-1 concentration was analyzed with a mouse total PAI-1 ELISA kit (IMSPAI1KTT, Innovative Research, Novi, MI) and the active plasma PAI-1 concentration was analyzed with a Clinical Proteomics:Article Title: Reversing PAI-1 deficiency in blood using mRNA lipid nanoparticles Article Snippet: .. The plasma PAI-1 concentration was analyzed with a mouse total PAI-1 ELISA kit (IMSPAI1KTT, Innovative Research, Novi, MI) and the active plasma PAI-1 concentration was analyzed with a Binding Assay:Article Title: Reversing PAI-1 deficiency in blood using mRNA lipid nanoparticles Article Snippet: .. The plasma PAI-1 concentration was analyzed with a mouse total PAI-1 ELISA kit (IMSPAI1KTT, Innovative Research, Novi, MI) and the active plasma PAI-1 concentration was analyzed with a |
![Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator <t>inhibitor</t> <t>1</t> (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_9123/pmc12829123/pmc12829123__gr3.jpg)